Categories: AppArtificial IntelligenceContent DistributionDataITMedtechResearchScienceTimeTools
The first AI-powered system to describe your clinical trial data automatically – save weeks of work and unlock insights early in your trials.
Investors 2
Mentions in press and media 5
| Date | Title | Description |
| 17.07.2023 | USA-based Readout AI raised an Undisclosed amount in pre-seed funding | Los Angeles, USA-based provider of a platform that analyzes data with appropriate statistics, Readout AI raised pre-seed investment. The company announced the investment on July 14, 2023. Meridian Street Capital led the financing for the co... |
| 17.07.2023 | Readout AI Secures Pre-Seed Funding to Decrease the Time from Clinical Trial Data to Clinical Trial Insight | Readout AI is announcing it has raised its pre-seed funding. The round, led by Meridian Street Capital, with participation from Mucker Capital, Necessary Ventures, and angel investor Ryan Fukushima (COO of Tempus and CEO of Pathos), will en... |
| 17.07.2023 |
Readout AI Gets Funding For Clinical Trial Software
| Los Angeles-based Readout AI has raised a pre-seed funding round, which will help it "turbocharge the biostatistical and medical writing tasks associated with clinical trials." Size of the funding was not announced. According to t... |
| 15.07.2023 | Readout AI Secures Pre-Seed Funding | Readout AI, a Los Angeles, CA-based provider of a platform that analyzes data with appropriate statistics, raised an undisclosed amount in Pre-Seed funding.
The round was led by Meridian Street Capital, with participation from Mucker Capita... |
| - | Readout AI | “The first AI-powered system to describe your clinical trial data automatically – save weeks of work and unlock insights early in your trials.” |
Reviews 0
